None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy males and females aged 20 to 64 years old 2. Subjects who are between 23 kg/m2 or more and less than 30 kg/m2 in BMI 3. Subjects who can make self-judgment and are voluntarily giving written informed consent
Exclusion criteria
Exclusion criteria: 1. Subjects who use medications affecting obesity, hyperlipidemia and lipid metabolism 2. Subjects who cannot stop using supplements and/or functional foods affecting obesity, hyperlipidemia and lipid metabolism 3. Subjects who are under treatment or have a history of disease e.g., serious liver disease, heart disease, respiratory insufficiency, endocrine disorder, metabolic diseases or food allergy 4. Subjects who have under treatment or a history of drug addiction and/or alcoholism 5. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 6. Subjects who have been diagnosed as familial hyperlipidemia 7. Subjects who has food allergy. 8. Subjects who are participating or planning to participate in other clinical studies to examine effects of food, medicine or cosmetics 9. Subjects who are planning to become pregnant during the study or are pregnant or lactating 10. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test Biochemistry test Urinalysis Blood pressure/pulse Weight/body mass index Medical interview Adverse event and side effect | — |
Countries
Japan
Contacts
KSO Corporation Sales department